LY248686 is an inhibitor of serotonin (S-hydroxytryptamine; 5-HT) and norepinephrine (NE) uptake in synaptosomal preparations of hypothalamus and cerebral cortex, and 5-HT uptake in human blood platelets, with inhibitor constants near nanomolar concentrations. Upon administration to rats 1 hour before sacrifi ce, LY248686 caused dose-dependent and parallel decreases of 5-HT and NE uptake in hypothalamus homogenates ex vivo. LY248686 is a positive enantiomer and was slightly more potent than its negative isomer, LY248685, as an inhibitor of 5-HT uptake. Both isomers were only weak inhibitors of dopamine (DA) uptake in striatal synaptosomes. The inhibitory effects on 5-HT and NE uptake after a single administration of LY248686 KEY WORDS: Uptake; Inhibitor; Serotonin; Norepineph rineThe extent of inhibition of serotonin (5-hydroxytrypta mine; 5-HT) and norepinephrine (NE) uptake by the tricyclic tertiary amine-containing antidepressant drugs depends on their relative degrees of metabolic N-demethylation. Amitriptyline, an inhibitor of 5-HT and NE uptake in nerve-ending preparations (synap tosomes), is converted in vivo to nortriptyline, a po tent and selective inhibitor of NE uptake, while imipra mine, a selective inhibitor of 5-HT uptake, is converted to desipramine, another potent and selective inhibitor